Abstract
Dyskeratosis congenita (DC) is a rare inherited disorder characterised by the early onset of reticulate skin pigmentation, nail dystrophy, and mucosal leucoplakia. In over 80% of cases bone marrow failure develops and this is the main cause of early mortality. The DCI gene responsible for the X linked form (MIM 305000) of dyskeratosis congenita has been mapped to Xq28 . In order to narrow the candidate gene region, genetic linkage analysis was performed in eight X linked pedigrees using a set of markers spanning Xq28. A maximum lod score of 5.31 with no recombinations was achieved with marker DXS1073. Two recombination events were identified; one ofthese uses X chromosome inactivation pattern analysis to determine carrier status and haplotype analysis to fine map the recombination breakpoint. The fine mapping of these recombination events has enabled the candidate gene region for X linked dyskeratosis congenita to be defined as the 1. 4 Mb interval between Xq3274 and DXS1 108. (7Med Genet 1998;35:993-996) Keywords : dyskeratosis congenita; X chromosome inactivation pattern; Xq28; DC1 Dyskeratosis congenita (DC) is a rare inherited disorder characterised by the early onset of reticulate skin pigmentation, nail dystrophy, and mucosal leucoplakia.' 2 In over 80% of patients bone marrow failure develops and this is the main cause of early mortality (I Dokal, unpublished observation).3 X linked inheritance (MIM 305000) is the most common form of the disease although both autosomal dominant (MIM 127550) and recessive (MIM 22430) forms are also recognised. DC appears to be distinct from the other more common inherited bone marrow failure syndrome, Fanconi's anaemia, with respect to the cellular sensitivity to clastogens.4 The DC1 gene responsible for the X linked form of the disease was mapped to Xq28 and subsequently localised to a 3.5 Mb region between DXS1684 and DXS 1108.5 6 The markers DXS52 and sKK5 were shown to be completely informative in pedigree DCR-007 (fig 3) and it was apparent that three boys, under the age of 7 years (V.1, V.3, and V.4), had all inherited the affected haplotype. However, each was asymptomatic and consequently the disease status was defined as unknown (fig 3) . An additional recombination event was observed in IV.18 from pedigree DCR-007 (fig 3) . It was possible to infer the phase of the haplotypes of her mother (III.26) from the haplotypes of the mother's brothers (III.21 and III.28) (fig 4) . It can be seen that the recombination breakpoint was between Xq3274 and DXS1 108 (fig 4) . A sample from the father, III.27, was not available and therefore it was not possible unambiguously to assign the phase of the markers G6PD Bcll, DXS1073, and F8c in IV.18. However, from the known linkage disequilibrium of SNPs in the G6PD region it was predicted that the father, III.27, had the genotype G6PD BclI(-) (fig 4) . This assumption was based on the fact that the haplotype G6PD EcoRI(-)/G6PD BcII(+) had not been observed in a population screen of white subjects from southern Italy.'4 By deduction, the maternally inherited haplotype in IV.18 was G6PD EcoRI(+)/G6PD BcdI(+) which implied that the recombination breakpoint was between Xq3274 and G6PD Bcl (fig 4) .
The usefulness of this recombination event in defining the DC 1 critical region was dependent on determining the carrier status of IV. 18. As a method of determining the carrier status, X chromosome inactivation analysis was performed in all available women in pedigree DCR-007. All obligate carriers of the disease (II.2, 11.6, III.4, and 11I.14) and those predicted to be carriers on the basis of inheritance of the affected DXS52/sKK5 haplotype (III.24, III.26, IV.2, and IV.5) had a completely skewed XCIP, as illustrated by III.26 in fig 5. In addition, those women predicted not to be carriers did not have a completely skewed XCIP (IV.7 and IV. 16) ( fig  5) . There was, therefore, a cosegregation of affected haplotype and skewed XCIP in pedigree DCR-007. IV.18 had a random XCIP as illustrated in fig 5 and was therefore predicted not to be a carrier of the disease. This must have been as a result of the loss of the mutated gene owing to the recombination event as described above. The location of the breakpoint and the carrier status of IV.18 mapped the DC1 gene distal to Xq3274.
Discussion
The recombination event in pedigree DCR-025 unambiguously placed the gene responsible for X linked dyskeratosis congenita distal to p39. This is the first report of a recominbination with DXS52. The marker DXS52 had previously had the highest lod score for linkage with DC 1 and was used as the method of determining carrier status by haplotype analysis. 6 The DXS52 VNTR was shown to be informative in pedigree DCR-025 unlike the DXS52 RFLP which was uninformative. 
